Skip to main content

The Fair Price Fallacy


The notion is rampant that producers and businesspersons are responsible for the supply of their goods at a so-called and so-believed fair price. 

What is a fair price after all? Is it not merely the supposition of a price which is only remotely convenient for the individual considering the product? Is it not merely the desired price for any given individual? 

Of course, the producer and the businessperson are easy to vilify in the public eye, as he or she is recognizable as a person who has or who has been fortunate, and the reader or onlooker is hardly familiar with the background or daily routine of that individual. 

However, the narrative of the supposed have-not is gripping and moralistic in stature, and the passerby may easily envision a way in which this individual's perceived misfortune may be corrected by a nominal adjustment of freedom for those whose routine struggles are diluted by their obscurity or their inconspicuousness. 

Nowhere is this discussion more prevalent than within the field of drugs and medicine. 

To become a better student of the discussion on fair pricing in the medical industry, one must investigate the enormity of the built-in, long-run costs of product and safety testing, research and development, clinical, regulatory and quality compliance, and the desensitizing factors of a consumer base widely insulated from drug prices through the apparatus of nationalized insurance and the attending incentives, applied to practitioners through the legal perils of medical malpractice and the aforementioned underexposed consumer, to comprehensively, rather than precisely, prescribe treatment. 

These total costs are incurred by companies whose several products might even fail to reach the market after the arduous 12-year stint from lab to medicine cabinet. 

And remember, of the many drugs that enter preclinical testing, only 0.001% of them will advance to human testing, and from this meager total only 20% will eventually be approved, putting the average probability of any single drug eventually reaching the market at 0.0002%.

By the way, there is roughly a $1 difference between the average price of gas in Detroit and that of San Francisco. 

I am wondering how this cost, as well as the costs of other goods and services, including utilities, rents and mortgages, might be reconciled by the popular and politicized model of deduction which has enabled an assignment of blame and crass scrutiny upon the executives of corporations who have merely priced their products at a market-clearing level which concomitantly satisfies the interests and applied valuations held by their shareholders who have personally taken a stake in their business. 

To be clear, there is nuanced contrast between high-order luxury goods and others which have evolved into basic essentials, expectations or even entitlements. Of course, the majority of these goods which are classified as basic were historically or incipiently deemed luxuries. But over time people adjust their expectation thresholds to anticipate even those returns which have never been procured of their own personal might but rather through a system of transfers politely codified as welfare or the common good

The primary distinction between the reception of drug prices and the prices of cars and other luxuries, for instance, where you will find tremendous differences in price by car brand, performance, etc., is the moralistic sentiment backing the institution of thought that individuals, or their perceived standing as something more vile or responsible through the name and edifices forming their corporate countenance, are endowed with that responsibility to target an ill-defined and completely-unknown price level that would be held as more fair. 

Of course, hardly anyone would legitimately claim that BMW or Mercedes-Benz ought to reduce their prices to align with the contentions of so-called or so-believed price pundits who claim to possess knowledge of the elusive fair pricing of products. 

Ultimately, I would urge any economist or logical thinker with a leaning toward truth or objectivity to first question whether a fair price may truly ever exist and more chiefly what any price organically signals to an individual or to the market. And in the case of Mylan, which today falls prey to the heated and accusatory abuse of Congressional opinion, the claims that Mylan has acquired some form of monopoly in the epinephrine autoinjector industry may find traction only due to yet another form of privilege honored by those very talking heads who today relentlessly and unabashedly denounce Mylan's CEO: that privilege of patent protection. 

Comments

Popular posts from this blog

Trump Victorious in 2024 Presidential Election

As of this hour, former President and now President-elect Donald Trump has secured his second term as the forty-seventh President of the United States. Trump’s victory comes after winning key battleground states Wisconsin, Michigan, Nevada, Arizona, Pennsylvania, and Georgia.  As for the popular vote, Trump was victorious there as well, winning by a one-and-a-half-percent margin. Despite these results, it’s evident that there remains a significant social and political problem in the United States, where politically-motivated violence, social unrest, crime and general instability have become rampant over the years since the death of George Floyd.  However, I’d say the fact that it was even this close is ominous for the years ahead. This was as clear as it gets for an election, that the incumbents (both Biden and Harris) are wholly unfit for any office, that they present a real and present danger where they’re allowed within twelve thousand miles of a school zone, let alone any...

Failure by Design

In the case for liberty, there is certainly some tolerance for error or failure, as it is generally suffered by the individual and not brought upon anyone by design . Wherever anyone seeks to empower government, however, one must be reasonably certain of the designs, the logic and the costs, and he must be equally honest about the unknowns as with the foreseeable consequences; after all, there is no margin for error where those designs are administered by the barrel of a gun.  One must necessarily remember that government is a monopoly on force and coercion, that force and coercion serve together as the modifying distinction between government and enterprise. It is a kind of force and coercion not by spirit or intention of written law but in accordance with the letter and understanding of the enforcers in their own time, in their own limited judgment and impaired conscience. As opposed to a state of liberty, where mistakes, failures and crimes are unavoidable in the face of human f...

From BC to AD to AI

Artificial intelligence is bound not only to render the ordinary human being boring by comparison, and in many cases practically unnecessary, but to dispose human beings to hostility toward each other where any dares pose a question or raise a concern instead of taking it up with a chatbot (or AI interface); such a course of action eventually assuming such a regular place in human affairs as to stand in entirely for human discourse and daily interaction.  This is not only a very real possibility when considering the future course of human ‘civilization’; it is more than likely imminent or already upon us.  It is left to be seen just what this will look like, just how this will play out, just what tolerance the species (and even beyond) has for such extremes which this technology is to bring about. Likewise, it remains to be seen whether a heavily-indebted society facing never-ending and unavoidable taxes (i.e. taxes on property) can even be expected to retrain and retool for t...